|
Pfizer Reports Fourth-Quarter and Full-Year 2007 Results
|
24 January 2008 |
|
Pfizer and Scil Finalize Agreement for Novel Cartilage Growth Factor
|
17 January 2008 |
|
Pfizer Wins Key New York State Court Ruling on Celebrex
|
11 January 2008 |
|
Pfizer and Taisho Finalize Agreement for Novel Schizophrenia Drug Candidate
|
07 January 2008 |
|
Pfizer Completes Sale of Consumer Healthcare Business
|
21 December 2007 |
|
Pfizer to Acquire CovX to Extend Biotherapeutics Investment
|
19 December 2007 |
|
Pfizer and Adolor Enter into Exclusive Worldwide Collaboration
|
06 December 2007 |
|
Pfizer to Acquire Coley Pharmaceutical Group
|
16 November 2007 |
|
Lipitor Demonstrated Significant Improvement or Stabilization of Kidney Function
|
06 November 2007 |
|
Taisho and Pfizer Sign a Letter of Intent for Taishoâs Schizophrenia Drug Candidate
|
03 November 2007 |
|
Pfizer to Appeal German Court Decision in Lipitor Patent Case
|
30 October 2007 |
|
Spanish Appellate Court Rules in Pfizer's Favor, Upholds Lipitor Patent
|
23 October 2007 |
|
Pfizer Reports Third-Quarter 2007 Results
|
19 October 2007 |
|
Pfizer Engages with Nation's Physicians Through Sermo to Improve Patient Care
|
15 October 2007 |
|
Pfizer Launches Independent Biotherapeutics and Bioinnovation Center
|
05 October 2007 |
|
Anti-Tumor Activity of Single-Agent Sunitinib Malate in Advanced Gastric Cancer
|
28 September 2007 |
|
First in a New Oral Class of HIV Medicines in 10 Years
|
24 September 2007 |
|
Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug
|
19 September 2007 |
|
Global Phase III Trial to Evaluate Sunitinib Malate Combined with Erlotinib
|
12 September 2007 |
|
Pfizer Launches Five Year, Three Country Initiative for Malaria Treatment and Education
|
06 September 2007 |